NT113, a pan-ERBB inhibitor with high brain penetrance, inhibits the growth of glioblastoma xenografts with EGFR amplification.

MLA

Yoshida, Yasuyuki, et al. “NT113, a Pan-ERBB Inhibitor with High Brain Penetrance, Inhibits the Growth of Glioblastoma Xenografts with EGFR Amplification.” Molecular Cancer Therapeutics, vol. 13, no. 12, Dec. 2014, pp. 2919–29. EBSCOhost, https://doi.org/10.1158/1535-7163.MCT-14-0306.

APA

Yoshida, Y., Ozawa, T., Yao, T.-W., Shen, W., Brown, D., Parsa, A. T., Raizer, J. J., Cheng, S.-Y., Stegh, A. H., Mazar, A. P., Giles, F. J., Sarkaria, J. N., Butowski, N., Nicolaides, T., & James, C. D. (2014). NT113, a pan-ERBB inhibitor with high brain penetrance, inhibits the growth of glioblastoma xenografts with EGFR amplification. Molecular Cancer Therapeutics, 13(12), 2919–2929. https://doi.org/10.1158/1535-7163.MCT-14-0306

Chicago

Yoshida, Yasuyuki, Tomoko Ozawa, Tsun-Wen Yao, Wang Shen, Dennis Brown, Andrew T Parsa, Jeffrey J Raizer, et al. 2014. “NT113, a Pan-ERBB Inhibitor with High Brain Penetrance, Inhibits the Growth of Glioblastoma Xenografts with EGFR Amplification.” Molecular Cancer Therapeutics 13 (12): 2919–29. doi:10.1158/1535-7163.MCT-14-0306.